THYROCARE
Thyrocare Technologies Limited (THYROCARE) Stock Analysis
Thyrocare Technologies Limited operates automated diagnostic laboratories offering affordable blood testing across India. It uses hub-and-spoke logistics and high-throughput analysers to serve doctors, hospitals, and consumers. The company is part of the PharmEasy group ecosystem. It is listed on Indian stock exchanges.
Healthcare › Diagnostics & Research
₹485.20
-2.89% 1W | +17.60% 52W
Market Cap
7.7k CR
P/E Ratio
44
52W High
₹662
52W Low
₹342.6
Div. Yield
1.91%
Beta
0.4
50 DMA
₹565.4
200 DMA
₹484.5
Profit Margin
20.1%
Inst. Own.
22%
⚠️ BREAKDOWN
⚠️ BREAKDOWN
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 135 | 148 | 135 | 154 | 157 | 177 | 166 | 187 | 193 | 217 | 196 | 224 | 240 |
| Expenses | 100 | 110 | 103 | 121 | 115 | 129 | 124 | 130 | 135 | 145 | 138 | 149 | 163 |
| Operating Profit | 35 | 38 | 32 | 34 | 42 | 48 | 42 | 57 | 58 | 71 | 58 | 75 | 77 |
| OPM % | 26% | 25% | 23% | 22% | 27% | 27% | 25% | 30% | 30% | 33% | 30% | 34% | 32% |
| Other Income | 1 | 3 | 3 | 3 | 4 | 3 | 4 | 5 | 5 | 3 | -1 | 5 | 5 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | -0 | 2 | 1 |
| Depreciation | 10 | 11 | 13 | 13 | 11 | 13 | 17 | 14 | 11 | 12 | 22 | 14 | 12 |
| Profit before tax | 25 | 28 | 20 | 23 | 34 | 37 | 28 | 47 | 50 | 63 | 35 | 64 | 68 |
| Tax % | 31% | 28% | 26% | 25% | 29% | 28% | 32% | 54% | 24% | 24% | 21% | 24% | 25% |
| Net Profit | 17 | 20 | 15 | 17 | 24 | 26 | 19 | 22 | 38 | 48 | 28 | 49 | 51 |
| EPS in Rs | 1.09 | 1.28 | 0.97 | 1.12 | 1.52 | 1.68 | 1.20 | 1.36 | 2.45 | 3.02 | 1.82 | 2.96 | 3.28 |
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 183 | 241 | 304 | 356 | 403 | 434 | 495 | 589 | 527 | 572 | 687 | 829 | 876 |
| Expenses | 110 | 147 | 189 | 212 | 249 | 261 | 323 | 353 | 403 | 432 | 498 | 566 | 594 |
| Operating Profit | 73 | 94 | 115 | 145 | 154 | 174 | 171 | 236 | 123 | 140 | 190 | 263 | 282 |
| OPM % | 40% | 39% | 38% | 41% | 38% | 40% | 35% | 40% | 23% | 24% | 28% | 32% | 32% |
| Other Income | 8 | 7 | -15 | 21 | 11 | 1 | 12 | 29 | 9 | 9 | 15 | 12 | 12 |
| Interest | 0 | 1 | 0 | 0 | 1 | 2 | 1 | 3 | 5 | 6 | 4 | 4 | 3 |
| Depreciation | 13 | 18 | 18 | 20 | 26 | 32 | 30 | 34 | 39 | 47 | 55 | 59 | 60 |
| Profit before tax | 68 | 82 | 82 | 145 | 138 | 140 | 152 | 228 | 89 | 96 | 145 | 213 | 231 |
| Tax % | 35% | 37% | 48% | 36% | 38% | 37% | 26% | 23% | 27% | 28% | 38% | 24% | |
| Net Profit | 44 | 52 | 43 | 93 | 85 | 88 | 113 | 176 | 64 | 69 | 91 | 163 | 176 |
| EPS in Rs | 2.98 | 3.21 | 2.66 | 5.79 | 5.38 | 5.58 | 7.13 | 11.10 | 4.06 | 4.45 | 5.76 | 10.24 | 11.08 |
| Dividend Payout % | 171% | 104% | 125% | 58% | 124% | 30% | 117% | 45% | 148% | 135% | 122% | 137% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 16.0% | 11.0% | 13.0% |
| Profit CAGR | 36.0% | 8.0% | 12.0% |
Shareholding Pattern
Promoters71.06%
FIIs4.85%
DIIs13.47%
Public10.61%
Promoters60.93%
FIIs4.96%
DIIs20.52%
Public13.61%
Promoters60.92%
FIIs5.37%
DIIs21.00%
Public12.71%
Promoters60.92%
FIIs5.43%
DIIs20.92%
Public12.71%
Promoters51.02%
FIIs9.37%
DIIs25.92%
Public13.69%
Promoters71.14%
FIIs9.99%
DIIs8.45%
Public10.40%
Promoters71.11%
FIIs2.90%
DIIs14.88%
Public11.11%
Promoters71.06%
FIIs2.41%
DIIs14.97%
Public11.57%
Promoters60.92%
FIIs5.37%
DIIs21.00%
Public12.71%
Promoters51.02%
FIIs9.37%
DIIs25.92%
Public13.69%
THYROCARE
Holdings Analysis
Key strengths & risk signals
87
Overall
89
Fundamental
85
Technical
Risks (0)
No risk signals found.
Strengths (4)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
BULLISH TREND! 50-day average (522.5) is above 200-day average (450.4) - positive signal.
BULLISH SENTIMENT! In last 30 days: 13 up days, 17 down days. Avg volume on up days: 1,396,289 vs down days: 306,638. Ratio: 4.55x
STRONG! Trading at 86.9% of 52W range - near yearly highs.
Fundamental & Technical Analysis
87Overall
89Fundamental
85Technical
Fundamental Breakdown
Growth Quality
28/30
Revenue CAGR: 16.7% (VERY GOOD, 13/15). Profit CAGR: 36.2% (EXCELLENT, 15/15).
Profit Margin
6/10
GOOD EFFICIENCY! 19.7% profit margin - above average profitability.
PEG Valuation
9/10
FAIRLY VALUED! PEG of 1.41 indicates reasonable valuation.
Dividend Yield
6/10
MODERATE DIVIDEND! 2.93% yield - some income benefit.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.05 - excellent financial health.
Public Holding
20/20
VERY LESS PUBLIC HOLDING! 11.95% public ownership - strong promoter/institutional control.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (522.5) is above 200-day average (450.4) - positive signal.
Price Position
8/10
STRONG POSITION! Current price (564.2) is above both moving averages.
Trend Pattern
10/20
AT RESISTANCE! Stock is at key resistance level.
52W Performance
8/10
GOOD YEAR! Stock gained 25.2% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 13 up days, 17 down days. Avg volume on up days: 1,396,289 vs down days: 306,638. Ratio: 4.55x
RSI
3/5
NEUTRAL! RSI at 58.7 - balanced momentum.
52W Range
5/5
STRONG! Trading at 86.9% of 52W range - near yearly highs.
Momentum
4/5
GOOD MOMENTUM! Price has grown across all timeframes - up 8.4% (1 week), 1.5% (1 month), 42.8% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.50 - stable stock, less market risk.
THYROCARE
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q4FY262026-07-27 | Concall PDF | |
| Q3FY262026-02-02 | Concall PDF | |
| Q1FY262025-10-17 | Concall PDF |
Peer Comparison
Healthcare · Diagnostics & Research · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| THYROCARE | ₹485.20 | 44 | 20.1% | 16.7% | 36.2% | +17.6% | 87 | BREAKDOWN | +34.2% | +10.8% | +24.4% | +7.1% |
| METROPOLIS | ₹530.40 | 54.6 | 11.8% | 12.8% | 10.0% | +7.9% | 67 | BREAKDOWN | +25.7% | +11.4% | +16.6% | +6.0% |
| VIJAYA | ₹1,381.70 | 76 | 21.9% | 21.0% | 26.9% | +41.3% | 74 | BREAKDOWN | +37.6% | +10.9% | +22.8% | +5.3% |
| SYNGENE | ₹386.10 | 70.3 | 6.1% | 5.4% | -12.0% | -40.0% | 57 | BOUNCE FROM SUPPORT | -110.4% | -106.1% | -15.8% | -29.0% |
| VIMTALABS | ₹522.50 | 29.6 | 18.9% | 8.9% | 17.2% | -21.8% | 57 | BREAKDOWN | +11.1% | -0.5% | +11.8% | -0.1% |
| KRSNAA | ₹533.30 | 18 | 11.6% | 16.6% | 17.8% | -32.4% | 61 | APPROACHING SUPPORT | -19.0% | -60.2% | +22.0% | +22.3% |
| SURAKSHA | ₹306.70 | 44.6 | 11.0% | 17.7% | 70.3% | +5.9% | 78 | BREAKDOWN | +38.3% | +106.3% | +20.7% | +7.6% |
| SAILIFE | ₹1,389.40 | 82.1 | 16.1% | 21.3% | 226.9% | +60.0% | 70 | BREAKDOWN | +21.2% | -29.7% | +11.7% | -7.9% |
Data from TradeAlone · Updated daily
THYROCARE News
Thyrocare Technologies Limited (THYROCARE) retraces post-breakout gains, down 7% intraday2026-08-13Thyrocare Technologies Limited (NSE: THYROCARE) clears resistance, moves up 5%2026-07-27Thyrocare Technologies Limited (THYROCARE) breaks out, gains 7% intraday2026-07-24Thyrocare Technologies Limited (thyrocare) Q1fy27: Revenue Up 24%, PAT Up 34%2026-07-23Thyrocare Technologies Limited (NSE: THYROCARE) gains 5% intraday2026-07-20Thyrocare Technologies Limited (NSE: THYROCARE) gains 5% intraday2026-07-14Thyrocare Technologies Limited (NSE: THYROCARE) pulls back after breakout, pulls back after, falls 5%2026-06-25Thyrocare Technologies Reports Strong Q4FY26 Results With 20% YoY Revenue Growth2026-05-07
